Sv Health Investors, Llc
- Regulatory AUM
- $1.1B
- Discretionary
- $1.1B
- Clients
- 21
- Avg AUM / client
- $51.4M
- Accounts
- 15
- Employees
- 26
AUM over time
Reported AUM from Form ADV filings, plotted by filing date · as of Mar 31, 2026
Who they serve
| Client type | Clients | AUM | % of AUM |
|---|---|---|---|
| Pooled investment vehicles (non-investment companies) | 21 | $1.1B | 100.0% |
Private funds (13)
Reported in Form ADV Section 7.B.(1), filing of Mar 2024 · $962M combined gross assets
| Fund | Type | Domicile | Gross assets | Owners |
|---|---|---|---|---|
| Sv Life Sciences Fund Iv Cf, L.P. | Venture Capital Fund | Delaware | $400M | 44 |
| Sv Life Sciences Fund Vi, L.P. | Venture Capital Fund | Delaware | $260M | 36 |
| Sv Life Sciences Fund V, L.P. | Venture Capital Fund | Delaware | $129M | 57 |
| Sv7 Growth Fund, L.P. | Venture Capital Fund | Delaware | $80.0M | 21 |
| Medtech Convergence Fund, L.P. | Venture Capital Fund | Delaware | $31.9M | 2 |
| International Life Sciences Fund Iii (Lp1), L.P. | Venture Capital Fund | Delaware | $23.9M | 37 |
| Sv Life Sciences Fund Vi Strategic Partners, L.P. | Venture Capital Fund | Delaware | $13.7M | 38 |
| Sv Life Sciences Fund Iv, L.P. | Venture Capital Fund | Delaware | $9.5M | 66 |
| Sv7 Growth Fund Strategic Partners, L.P. | Venture Capital Fund | Delaware | $9.4M | 48 |
| Sv Life Sciences Fund V Strategic Partners, L.P. | Venture Capital Fund | Delaware | $3.3M | 72 |
| International Life Sciences Fund Iii Co Investment, L.P. | Venture Capital Fund | Delaware | $574K | 27 |
| International Life Sciences Fund Iii Strategic Partners, L.P. | Venture Capital Fund | Delaware | $420K | 37 |
| Sv Life Sciences Fund Iv Strategic Partners, L.P. | Venture Capital Fund | Delaware | $264K | 91 |
People (9)
| Name | Role / title | Credentials | With firm since | Ownership |
|---|---|---|---|---|
| Bingham, Catherine, Elizabeth | Managing Partner | Jan 2006 (21y) | Less than 5% | |
| Hill, Eugene, Dubose | Managing Partner | Jan 2006 (21y) | 5% – 10% | |
| Ross, Michael, Jay | Managing Partner | Jan 2006 (21y) | 10% – 25% | |
| Flynn, Thomas, Joseph | Managing Partner | Jan 2014 (13y) | 10% – 25% | |
| Laviolette, Paul, Arthur | Managing Partner And Chief Operating Officer | Jan 2014 (13y) | 10% – 25% | |
| Balmuth, Michael, Hart | Managing Partner | Jan 2018 (9y) | 10% – 25% | |
| Faduski, Brent, Michael | Chief Financial Officer And Chief Compliance Officer | Jan 2018 (9y) | Less than 5% | |
| Madden, Greg, Anthony | Managing Partner | Jan 2021 (6y) | 10% – 25% | |
| Trbovic, Nikola, Nmn | Managing Partner | Jan 2024 (3y) | 5% – 10% |
Undisclosed: 0% – 40% of the firm is not attributable from the filed Schedule A bands.
Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.
Private funds (13, $962M gross assets)
| Fund | Type | Gross assets | Min. investment | Owners |
|---|---|---|---|---|
| Sv Life Sciences Fund Iv Cf, L.P. | Venture Capital Fund | $400M | $5.0M | 44 |
| Sv Life Sciences Fund Vi, L.P. | Venture Capital Fund | $260M | $1.5M | 36 |
| Sv Life Sciences Fund V, L.P. | Venture Capital Fund | $129M | $1.5M | 57 |
| Sv7 Growth Fund, L.P. | Venture Capital Fund | $80.0M | $5.0M | 21 |
| Medtech Convergence Fund, L.P. | Venture Capital Fund | $31.9M | $0 | 2 |
| International Life Sciences Fund Iii (Lp1), L.P. | Venture Capital Fund | $23.9M | $10.0M | 37 |
| Sv Life Sciences Fund Vi Strategic Partners, L.P. | Venture Capital Fund | $13.7M | $50.0K | 38 |
| Sv Life Sciences Fund Iv, L.P. | Venture Capital Fund | $9.5M | $1.0M | 66 |
| Sv7 Growth Fund Strategic Partners, L.P. | Venture Capital Fund | $9.4M | $5.0M | 48 |
| Sv Life Sciences Fund V Strategic Partners, L.P. | Venture Capital Fund | $3.3M | $25.0K | 72 |
| International Life Sciences Fund Iii Co Investment, L.P. | Venture Capital Fund | $574K | $10.0K | 27 |
| International Life Sciences Fund Iii Strategic Partners, L.P. | Venture Capital Fund | $420K | $50.0K | 37 |
| Sv Life Sciences Fund Iv Strategic Partners, L.P. | Venture Capital Fund | $264K | $25.0K | 91 |
From Form ADV Section 7.B private fund reporting.
Documents (1 archived)
| Form | Period | Size | |
|---|---|---|---|
| Form ADV (full filing) | 03/31/2026 | 4.54 MB | View · PDF · Source ↗ |
Archived copies of the firm's regulatory filings, versioned by content hash.
Disciplinary disclosures
No disciplinary events reported on the firm's latest Form ADV filing.
How they charge
- • Percentage of assets under management
- • Performance-based fees
Services
- • Portfolio management for pooled investment vehicles
Custody
Firm reports it does not have custody of client funds or securities (Item 9.A).
No custodian data reported or mined yet.
Source
All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Mar 31, 2026.
View current Form ADV (SEC/IAPD) ↗